Merus N.V. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Merus N.V. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire August 04, 2025 UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics(R), Triclonics(R) and ADClonics(R)), today announced that […]